UNSPSC 51372304: Carperidine

This classification denotes an opioid receptor agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LZ6E4G9827. European Medicines Agency schedules Carperidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06138MIG. Carperidine generally arises in the molecular formula C17H24N2O3.

UNSPSC 51372304 Carperidine, a Commodity code, encompasses pharmaceutical products and medical supplies procured by state and local health agencies, but recent activity under this code classification shows limited direct relevance. The single recent opportunity identified—Seminole County, Florida's IFB 60459723LAS—tags a procurement for naloxone and drug deactivation systems, products that fall outside the nominal scope of carperidine itself (a pharmaceutical compound with specific clinical applications). State and local health departments, county community health programs, and emergency response agencies use UNSPSC codes in this family to classify pharmaceutical and medical supplies inventory, but the mismatch between the code and the actual commodities being solicited suggests either a tagging error or a broader use of the code to capture naloxone and harm-reduction supplies that may not align with carperidine's therapeutic category.

Seminole County, Florida posted the naloxone procurement on June 30, 2026, with a response deadline of July 26, 2023 (date variance in the source). The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract offers an initial two-year term with a one-year renewal option; vendors must meet E-Verify compliance, drug-free workplace certification, and standard insurance requirements (workers' compensation, commercial general liability, professional liability), with potential FEMA funding creating additional federal compliance obligations. The procurement does not designate set-asides for disadvantaged enterprises. Given the sparse recent activity and the categorical mismatch between the code label and the solicitation, this code warrants close monitoring but does not presently show a consistent pipeline of carperidine-specific purchases from state and local agencies.